Neuberger Berman Group LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 351 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
Neuberger Berman Group LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,633,410
+5.8%
71,221
-0.0%
0.01%
+14.3%
Q2 2023$8,159,435
-16.9%
71,249
+0.0%
0.01%
-22.2%
Q1 2023$9,817,217
+1687.3%
71,227
+1580.3%
0.01%
+800.0%
Q4 2022$549,290
+16.9%
4,239
-0.3%
0.00%
Q3 2022$470,000
+51.1%
4,250
+2.5%
0.00%
Q2 2022$311,000
+40.1%
4,145
+46.0%
0.00%
Q1 2022$222,000
-96.5%
2,840
-92.5%
0.00%
-100.0%
Q4 2020$6,424,000
-31.3%
37,779
-38.6%
0.01%
-36.4%
Q2 2019$9,345,000
+30.7%
61,500
+2.5%
0.01%
+22.2%
Q1 2019$7,151,000
+5.6%
60,000
-3.3%
0.01%0.0%
Q4 2018$6,772,000
-68.1%
62,053
-52.8%
0.01%
-62.5%
Q3 2018$21,247,000
+21.6%
131,553
-0.5%
0.02%
+26.3%
Q2 2018$17,477,000
+837.1%
132,220
+425.1%
0.02%
+850.0%
Q1 2018$1,865,000
+88.6%
25,178
+41.6%
0.00%
+100.0%
Q4 2017$989,000
-12.8%
17,775
-28.9%
0.00%0.0%
Q3 2017$1,134,00025,0000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Perceptive Advisors 2,878,979$69,182,0007.27%
Eventide Asset Management 259,100$6,226,0000.97%
GLADE BROOK CAPITAL PARTNERS LLC 251,000$6,032,0000.93%
IMS Capital Management 32,215$774,0000.91%
Perceptive Advisors 350,000$8,413,0000.88%
Benchmark Capital Advisors 34,900$839,0000.58%
BECK CAPITAL MANAGEMENT, LLC 24,744$636,0000.49%
SABBY MANAGEMENT, LLC 352,100$8,461,0000.47%
Hatteras Alternative Mutual Funds, LLC 39,404$947,0000.46%
Potomac Capital Management, Inc. 22,100$531,0000.45%
View complete list of SAREPTA THERAPEUTICS INC shareholders